NEW YORK (dpa-AFX) – For the US stock exchanges, which were ailing the day before, an inconsistent start is indicated on Tuesday. The broker IG indexed the Dow Jones Industrial three quarters of an hour before the start of trading, 0.20 percent lower at 33 676 points. At the beginning of the week, the best-known American stock index had already paid some tribute to its recent record hunt. The tech-heavy Nasdaq 100 
IG, however, expects 0.53 percent higher at 13,892 meters.
The news that the responsible authorities in the USA had recommended a temporary suspension of corona vaccinations with the active ingredient from Johnson & Johnson (J&J) turned out to be a small dampener for the Dow. This means a serious setback for the country’s vaccination campaign, as the active ingredient – unlike the preparations from Pfizer / Biontech and Moderna, for example – only needs to be administered once and not twice.
Meanwhile, the Nasdaq 100 benefited somewhat from US consumer prices for March. Without energy and food, these rose a little more than expected, commented Patrick Boldt from Landesbank Helaba. The core inflation can still be classified as moderate. “Against this background, inflation worries should not get any bigger for the time being and the monetary authorities will not feel pressured to take back the expansionary monetary policy.”
The CDC and the FDA responded to six cases of sinus vein thrombosis in the United States following vaccination with their joint J&J drug recommendation. The shares of the pharmaceutical company then sagged by two and a half percent in pre-market trading. In contrast, the shares in Biontech and Pfizer rose by 2.7 and one percent, respectively, while Moderna even went up by over six percent.
At American Airlines, the news that the airline expects an adjusted loss of 2.8 billion US dollars for the first quarter caused a price slide of more than three percent.
– .
